Bristol Myers, Pfizer, AbbVie Drugs Likely To Face U.S. Price Negotiation 0 13.03.2023 14:24 International Business Times The blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and AbbVie's leukemia treatment Imbruvica are likely to be among 10 big-selling medicines subject to U.S. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
